Abstract:
A digital camera is provided with a photographing lens having a aperture mechanism, an imaging section, including an image sensor for capturing a subject image via the photographing lens, a display section capable of displaying image information, an aperture drive section for driving the aperture mechanism to a specified position in response to manual operation of a preview instruction member, and a control section for causing execution of an exposure operation for a specified period in the imaging section, and causing display of a moving image on the display section based on image data acquired by the exposure operation. The control section stops the moving image display during drive of the aperture mechanism by the aperture drive mechanism, to thereby prevent unnatural variation in brightness of an image in live view display when a preview operation is carried out.
Abstract:
A digital camera is provided with a photographing lens having a aperture mechanism, an imaging section, including an image sensor for capturing a subject image via the photographing lens, a display section capable of displaying image information, an aperture drive section for driving the aperture mechanism to a specified position in response to manual operation of a preview instruction member, and a control section for causing execution of an exposure operation for a specified period in the imaging section, and causing display of a moving image on the display section based on image data acquired by the exposure operation. The control section stops the moving image display during drive of the aperture mechanism by the aperture drive mechanism, to thereby prevent unnatural variation in brightness of an image in live view display when a preview operation is carried out.
Abstract:
The present invention provides compositions comprising compounds having formula (I): and additionally provides methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein. In certain embodiments, the compositions are for systemic (e.g., oral) administration. In certain embodiments, methods for the treatment of various disorders including inflammatory or autoimmune disorders comprise systemically (e.g., orally) administering to a subject in need thereof a therapeutically effective amount of a compound of formula (I).
Abstract:
A 2-iminoimidazole derivative represented by the formula: {wherein R1, R2 and R3 represent hydrogen, optionally substituted C1-6 alkyl, etc.; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R10-R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc., and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocycle], etc.}or salt thereof.
Abstract translation:由下式表示的2-亚氨基咪唑衍生物:其中R 1,R 2和R 3表示氢,任选取代的C 1-6烷基等; R 6表示氢,C 1-6烷基,C 1-6烷氧羰基等; Y 1表示单键,-CH 2 - 等; Y 2表示单键,-CO-等; 并且Ar表示氢,由下式表示的基团:其中R 10 -R 14表示氢,C 1-6烷基,羟基,C 1-6烷氧基等,R 11和R 12 >或R 12和R 13可以键合在一起形成5-至8-元杂环等}或其盐。
Abstract:
A display apparatus includes a display unit that displays plural images corresponding to plural image data, respectively, the plural image data being associated with plural pieces of position information which are different from one another; a display position converter that converts the position information associated with each image into display position information that reflects a positional relationship relative to the position information of another image on a display screen of the display unit; and a display controller that causes the display unit to display the plural images based upon the display position information of each image converted by the display position converter.
Abstract:
A 2-iminopyrrolidine derivative represented by the formula: {wherein ring B represents a benzene ring, pyridine ring, etc.; R101–R103 represent hydrogen, halogen, C1-6 alkyl, etc.; R5 represents hydrogen, C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, etc.; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R10—R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc.; and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocyclic ring], etc.}, or a salt thereof.
Abstract translation:由下式表示的2-亚氨基吡咯烷衍生物:其中环B表示苯环,吡啶环等; R 101为-O-,卤素,C 1-6烷基等; R 5表示氢,C 1-6烷基,C 1-6烷氧基-C 1-6烷基 等等 R 6表示氢,C 1-6烷基,C 1-6烷氧基羰基等; Y 1表示单键,-CH 2 - 等; Y 2表示单键,-CO-等; 和Ar表示氢,由下式表示的基团:其中R 10 -R 14表示氢,C 1-6烷基,羟基 C 1-6烷氧基等; 并且R 11和R 12或R 12和R 13可以键合在一起形成5-8个 - 杂环]等,或其盐。
Abstract:
The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.
Abstract:
The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.
Abstract:
A 2-iminopyrrolidine derivative represented by the formula: {wherein ring B represents a benzene ring, pyridine ring, etc.; R101-R103 represent hydrogen, halogen, C1-6 alkyl, etc.; R5 represents hydrogen, C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, etc.; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R10-R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc.; and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocyclic ring], etc.}, or a salt thereof.
Abstract translation:由下式表示的2-亚氨基吡咯烷衍生物:其中环B表示苯环,吡啶环等; R 101为-O-,卤素,C 1-6烷基等; R 5表示氢,C 1-6烷基,C 1-6烷氧基-C 1-6烷基 等等 R 6表示氢,C 1-6烷基,C 1-6烷氧基羰基等; Y 1表示单键,-CH 2 - 等; Y 2表示单键,-CO-等; 和Ar表示氢,由下式表示的基团:其中R 10 -R 14表示氢,C 1-6烷基,羟基 C 1-6烷氧基等; 并且R 11和R 12或R 12和R 13可以键合在一起形成5-8个 - 杂环]等,或其盐。
Abstract:
The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein.